Trial Outcomes & Findings for Effect of Tetanus on Neuromuscular Junction Monitor Performance in Pediatric Patients (NCT NCT02498678)

NCT ID: NCT02498678

Last Updated: 2015-12-11

Results Overview

Time to recovery to train of four 0,9 (90%). When the fourth stimulus value (T4) divided by the first stimulus (T1) reaches the ratio of 0.9 (T4 / T1)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

50 participants

Primary outcome timeframe

An expected average of 60 minutes

Results posted on

2015-12-11

Participant Flow

Participant milestones

Participant milestones
Measure
Control Group
After verifying the absence of sevoflurane through the gas analyzer, TOF monitor mode starts with stimuli every 12 to 15 seconds. After 1 minute (min) stimulation, calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes.
Tetanus Group
After verifying the absence of sevoflurane through the gas analyzer, a 50-Hz tetanic stimulation will be applied for 5 s and followed after 1 min by TOF stimulation every 15 s. After 1 minute (min) calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes. Tetanus: tetanic electric stimulation
Overall Study
STARTED
25
25
Overall Study
COMPLETED
25
23
Overall Study
NOT COMPLETED
0
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Control Group
After verifying the absence of sevoflurane through the gas analyzer, TOF monitor mode starts with stimuli every 12 to 15 seconds. After 1 minute (min) stimulation, calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes.
Tetanus Group
After verifying the absence of sevoflurane through the gas analyzer, a 50-Hz tetanic stimulation will be applied for 5 s and followed after 1 min by TOF stimulation every 15 s. After 1 minute (min) calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes. Tetanus: tetanic electric stimulation
Overall Study
interference from the surgical team
0
2

Baseline Characteristics

Effect of Tetanus on Neuromuscular Junction Monitor Performance in Pediatric Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Group
n=25 Participants
After verifying the absence of sevoflurane through the gas analyzer, TOF monitor mode starts with stimuli every 12 to 15 seconds. After 1 minute (min) stimulation, calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes.
Tetanus Group
n=23 Participants
After verifying the absence of sevoflurane through the gas analyzer, a 50-Hz tetanic stimulation will be applied for 5 s and followed after 1 min by TOF stimulation every 15 s. After 1 minute (min) calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes. Tetanus: tetanic electric stimulation
Total
n=48 Participants
Total of all reporting groups
Age, Continuous
6.8 years
STANDARD_DEVIATION 2.7 • n=5 Participants
5.6 years
STANDARD_DEVIATION 2.35 • n=7 Participants
6.2 years
STANDARD_DEVIATION 2.6 • n=5 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
3 Participants
n=7 Participants
12 Participants
n=5 Participants
Sex: Female, Male
Male
16 Participants
n=5 Participants
20 Participants
n=7 Participants
36 Participants
n=5 Participants
Region of Enrollment
Brazil
25 participants
n=5 Participants
23 participants
n=7 Participants
48 participants
n=5 Participants
Body mass index
17.2 kilogram per square meter
STANDARD_DEVIATION 7.6 • n=5 Participants
15.7 kilogram per square meter
STANDARD_DEVIATION 1.3 • n=7 Participants
16.5 kilogram per square meter
STANDARD_DEVIATION 5.56 • n=5 Participants
Growth chart percentiles
38.5 percentile
STANDARD_DEVIATION 27 • n=5 Participants
44.6 percentile
STANDARD_DEVIATION 22.2 • n=7 Participants
41.3 percentile
STANDARD_DEVIATION 24.9 • n=5 Participants
ASA physical status
1
15 participants
n=5 Participants
18 participants
n=7 Participants
33 participants
n=5 Participants
ASA physical status
2
10 participants
n=5 Participants
5 participants
n=7 Participants
15 participants
n=5 Participants

PRIMARY outcome

Timeframe: An expected average of 60 minutes

Time to recovery to train of four 0,9 (90%). When the fourth stimulus value (T4) divided by the first stimulus (T1) reaches the ratio of 0.9 (T4 / T1)

Outcome measures

Outcome measures
Measure
Control Group
n=25 Participants
After verifying the absence of sevoflurane through the gas analyzer, TOF monitor mode starts with stimuli every 12 to 15 seconds. After 1 minute (min) stimulation, calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes.
Tetanus Group
n=23 Participants
After verifying the absence of sevoflurane through the gas analyzer, a 50-Hz tetanic stimulation will be applied for 5 s and followed after 1 min by TOF stimulation every 15 s. After 1 minute (min) calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes. Tetanus: tetanic electric stimulation
Train of Four 0,9 (90%)
49.9 minutes
Standard Deviation 12.2
41.7 minutes
Standard Deviation 13.1

PRIMARY outcome

Timeframe: An expected average of 60 minutes

T1 height documentation when train of four reaches 0,9 (90%)

Outcome measures

Outcome measures
Measure
Control Group
n=25 Participants
After verifying the absence of sevoflurane through the gas analyzer, TOF monitor mode starts with stimuli every 12 to 15 seconds. After 1 minute (min) stimulation, calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes.
Tetanus Group
n=23 Participants
After verifying the absence of sevoflurane through the gas analyzer, a 50-Hz tetanic stimulation will be applied for 5 s and followed after 1 min by TOF stimulation every 15 s. After 1 minute (min) calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes. Tetanus: tetanic electric stimulation
T1 Height
95.3 percentage of T1 height
Standard Deviation 15.8
69.3 percentage of T1 height
Standard Deviation 8.7

SECONDARY outcome

Timeframe: An expected average of 60 minutes

Time, in minutes, for the stabilization T1 height (maximum acceptable variation of up to 5%) before administration of neuromuscular blocking agent. According to the guidelines for good clinical research practice in pharmacodynamics studies of neuromuscular blocking agents, the monitor must present a stable response of T1 height (baseline) for a period of 2-5 min before administration of an neuromuscular blocking agents.

Outcome measures

Outcome measures
Measure
Control Group
n=25 Participants
After verifying the absence of sevoflurane through the gas analyzer, TOF monitor mode starts with stimuli every 12 to 15 seconds. After 1 minute (min) stimulation, calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes.
Tetanus Group
n=23 Participants
After verifying the absence of sevoflurane through the gas analyzer, a 50-Hz tetanic stimulation will be applied for 5 s and followed after 1 min by TOF stimulation every 15 s. After 1 minute (min) calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes. Tetanus: tetanic electric stimulation
Time to Obtain T1 Height Stability
195 seconds
Standard Deviation 203
116 seconds
Standard Deviation 81.6

SECONDARY outcome

Timeframe: An expected average of 60 minutes

Electric current (milliampere) calculated by the monitor calibration

Outcome measures

Outcome measures
Measure
Control Group
n=25 Participants
After verifying the absence of sevoflurane through the gas analyzer, TOF monitor mode starts with stimuli every 12 to 15 seconds. After 1 minute (min) stimulation, calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes.
Tetanus Group
n=23 Participants
After verifying the absence of sevoflurane through the gas analyzer, a 50-Hz tetanic stimulation will be applied for 5 s and followed after 1 min by TOF stimulation every 15 s. After 1 minute (min) calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes. Tetanus: tetanic electric stimulation
Monitor Settings - Electric Current
48.2 milliampere
Standard Deviation 12.1
47.2 milliampere
Standard Deviation 13.5

SECONDARY outcome

Timeframe: An expected average of 60 minutes

Sensitivity calculated by the monitor calibration, It is a numeric value that ranges from 1 to 512, but there is no measurement unit provided. Using the default CAL 2 function, the TOF-Watch® SX monitor automatically determines the sensitivity for a specific patient. The sensitivity can be adjusted between 1 and 512, where 512 represents the most sensitive setting. A sensitivity setting of 157 is the default value. This value represents how the monitor measures motor response of the patient to electrical stimulation of train of four (TOF). If the patient has intense motor response, the monitor reduces its sensitivity. If the patient has poor motor response, the monitor increase your sensitivity.

Outcome measures

Outcome measures
Measure
Control Group
n=25 Participants
After verifying the absence of sevoflurane through the gas analyzer, TOF monitor mode starts with stimuli every 12 to 15 seconds. After 1 minute (min) stimulation, calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes.
Tetanus Group
n=23 Participants
After verifying the absence of sevoflurane through the gas analyzer, a 50-Hz tetanic stimulation will be applied for 5 s and followed after 1 min by TOF stimulation every 15 s. After 1 minute (min) calibration and supramaximal stimulation will be ensured by the built-in calibration function (CAL 2) of the TOF-Watch®. The stability of the response will be documented by at least 2 to 5 min \[\< 5% variation in the first response (T1) in the TOF\]. Monitoring of neuromuscular junction will be held until recovery of the TOF ratio to 0.9 (90%), an expected average of 60 minutes. Tetanus: tetanic electric stimulation
Monitor Settings - Sensitivity
128 units on a scale from 1 to 512
Standard Deviation 41.1
103.8 units on a scale from 1 to 512
Standard Deviation 49.8

Adverse Events

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Tetanus Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Ricardo Vieira Carlos

Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo

Phone: 55-11-99911-6677

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place